Myeloma Paper of the Day, August 20th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
MEDICI study analysis of real-world data on t(11;14) prevalence and disease biology in myeloma finds 22.1% prevalence (higher among African Americans and with light chain disease), 27% in RRMM, less 1q and more IRF4 mutations.”
Title: Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Authors: Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu, Anna Lysén, Norma C Gutierrez, Fernando Escalante, Dorotea Fantl, Roman Hajek, Fernanda Seguro, Gurbakhash Kaur, Rosane Isabel Bittencourt, Sandra Bašić-Kinda, Michael P Chu, Hana Safah, Joaquín Martínez-López, Edvan de Queiroz Crusoé, Danielle Leao Cordeiro De Farias, Massimo Offidani, Elham Askari, Omur Gokmen SEVINDIK, Vladimir Maisnar, Chieh-Lin Jerry Teng, Olivia Hughes, Rebekah Taylor, Kristin Lehn, Dai Feng, Raphaële Thiébaut-Millot, Xiaotong Li, Lauren Murray, Paul Jung, Emily L Rossi, Sarah Kongpachith, Alexander Nichol, Jeremy A Ross, Carlos Hader
You can read the Full Article on Blood Advances.
You can find more posts featuring Robert Orlowski on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023